chr22-37061607-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000403888.8(KCTD17):c.853C>T(p.Arg285Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000419 in 1,599,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R285H) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000403888.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD17 | NM_001282684.2 | c.853C>T | p.Arg285Cys | missense_variant | 8/9 | ENST00000403888.8 | NP_001269613.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCTD17 | ENST00000403888.8 | c.853C>T | p.Arg285Cys | missense_variant | 8/9 | 1 | NM_001282684.2 | ENSP00000385096 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000194 AC: 46AN: 236932Hom.: 0 AF XY: 0.000194 AC XY: 25AN XY: 129152
GnomAD4 exome AF: 0.000437 AC: 632AN: 1447230Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 310AN XY: 720272
GnomAD4 genome AF: 0.000249 AC: 38AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000215 AC XY: 16AN XY: 74488
ClinVar
Submissions by phenotype
Myoclonic dystonia 26 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 292 of the KCTD17 protein (p.Arg292Cys). This variant is present in population databases (rs199921196, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with KCTD17-related conditions. ClinVar contains an entry for this variant (Variation ID: 571150). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The cysteine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.802C>T (p.R268C) alteration is located in exon 7 (coding exon 7) of the KCTD17 gene. This alteration results from a C to T substitution at nucleotide position 802, causing the arginine (R) at amino acid position 268 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | KCTD17: BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at